(Q72553141)
Statements
Safety and efficacy of thymopentin in zidovudine (AZT)-treated asymptomatic HIV-infected subjects with 200-500 CD4 cells/mm3: a double-blind placebo-controlled trial (English)
G Goldstein
M A Conant
G Beall
H A Grossman
J E Galpin
G Blick
L H Calabrese
R L Hirsch
A Fisher
1 March 1995